Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - TOTAL LIABILITIES
Total Liabilities HALO - Halozyme Therapeutics, Inc.
1.65 B
LAST VALUE
34.82%
2 YEAR CAGR
53.85%
5 YEAR CAGR
29.77%
10 YEAR CAGR